Vivavision Biotech, Inc

This early-stage study tests a new nasal spray called VVN432 in 60 people—first in healthy volunteers, then in patients with chronic sinusitis. The goal is to check if the spray is safe and how the body processes it. It is not a cure, but aims to ease symptoms of long-term sinus …